Centrum 7/6  banner

2021

Kroger’s Lindholz named Rx Executive of the Year

Kroger’s Lindholz named Rx Executive of the Year

CINCINNATI — Colleen Lindholz and her team are continuing to lead initiatives and create innovative programs to help people live happier, healthier lives. As the president of Kroger Health, the health care division of Kroger Co., she heads up a group of 22,000 health care professionals. Together they provide health and wellness solutions to more

Pharmacy Outlook: B. Douglas Hoey, NCPA

Pharmacy Outlook: B. Douglas Hoey, NCPA

On January 10, 2020, cheers erupted in the National Community Pharmacists Association’s headquarters when we learned the U.S. Supreme Court had decided to hear Rutledge v. Pharmaceutical Care Management Association, a case to determine whether ERISA preempts a state law regulating pharmacy benefit managers. NCPA has been fighting to rein in PBMs for years, and

Pharmacy Outlook: Stephen Ubl, PhRMA

Pharmacy Outlook: Stephen Ubl, PhRMA

At the start of 2020, our members were focused on continuing their research and development of transformative treatments for the most difficult diseases, such as cell and gene therapies. We planned on making strides on new medicines for chronic diseases like diabetes, heart disease and cancer. And we planned on pushing for policy solutions that

Pharmacy Outlook: Sheila Arquette, NASP

Pharmacy Outlook: Sheila Arquette, NASP

The COVID-19 pandemic has altered life as we know it and impacted each of us in a very personal way. The scale and magnitude of the pandemic brought sudden and unexpected challenges and opportunities for all specialty pharmacy stakeholders. As we look to the future, we must consider the impacts the COVID-19 pandemic has had

Pharmacy Outlook: Scott Knoer, APhA

Pharmacy Outlook: Scott Knoer, APhA

How did 2020 affect American Pharmacists Association members? “Profoundly” is an understatement. “Irrevocably” is appropriate. “Positively” may be hard to see right now, but I believe it’s the truth. Pharmacists emerged from last year — a year that few words can adequately describe — stronger, and they enter 2021 empowered like never before. The way

Pharmacy Outlook: Dan Leonard, AAM

Pharmacy Outlook: Dan Leonard, AAM

For most U.S. patients, affordable prescription medicines are just a short drive or walk from home to the drug store — or medicines are delivered right to their mailbox. This degree of convenience takes a lot of work behind the scenes. To get biosimilars and generics from the manufacturer to the pharmacy to the patients,

Pharmacy Outlook: Laura Cranston, PQA

Pharmacy Outlook: Laura Cranston, PQA

It is a bittersweet opportunity to write this Healthcare Outlook for 2021 on behalf of the Pharmacy Quality Alliance. As the outgoing chief executive officer, it has been my honor and privilege to serve PQA and its 250 organizational members since the alliance was created, initially as a public-private partnership with the Centers for Medicare

Pharmacy Outlook: Chip Davis, HDA

Pharmacy Outlook: Chip Davis, HDA

Our nation is at a defining moment, as we transition to a new administration and Congress and continue to respond to the COVID-19 pandemic. From a health care delivery perspective, the logistics expertise of our industry has never been more relied upon, and scrutinized, than it is today. As the calendar turns to 2021, eradicating

Pharmacy Outlook: Scott Melville, CHPA

Pharmacy Outlook: Scott Melville, CHPA

Despite the difficult realities of COVID-19, and the tremendous challenge, pain and uncertainty it has created, 2020 was also a year of incredible progress for self-care in the United States. From manufacturers to retailers, we at Consumer Healthcare Products Association are proud of the pivotal role our extended industry has played in providing and maintaining

Pharmacy operators on chain drug industry’s 2021 outlook

Pharmacy operators on chain drug industry’s 2021 outlook

The year that was like no other is over, and pharmacy operators are looking forward to more normal times, at least starting around summer. One question is how much the elevated status of pharmacists during the pandemic will propel long-term gains for the profession. On the following pages top industry executives address that question and

Bob Kwait: The once and future merchant

Bob Kwait: The once and future merchant

To once again paraphrase that age-old maxim from a time-honored religious treatise: To those who know Bob Kwait, no explanation is necessary; to those who do not, no explanation is possible. Through a retailing career marked by innovation, creative thinking and, at times, controversy, Kwait stamped the chain drug community with a brand of thinking

1 9 10 11
PP_1170x120_10-25-21